Global Hiv Drugs Market Key Players Competitive Survey Report 2023
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
The global Hiv Drugs market size in 2022 is 31300.0 million US dollars, and it is expected to be XX million US dollars by 2029, with a compound annual growth rate of 3.70% expected in 2023-2029.
MARKET COMPETITIVE LANDSCAPE:
The main players in the Hiv Drugs market include ViiV Healthcare (U.S.), Gilead Sciences Inc. (U.S.), Glaxo Smith Kline PLC (U.K.), Merck Sharp & Dohme Corp. (France), and Bristol-Myers Squibb Company (U.S.). The share of the top 3 players in the Hiv Drugs market is XX%.
REGION SHARE:
The report covers the market size information of North America, Europe, Asia Pacific, Latin America, Middle East and Africa, and North America accounted for XX%, Europe accounted for XX% of Hiv Drugs market, and Asia Pacific accounted for XX%.
SEGMENT OVERVIEW:
The report segments the market by Type and Application. Integrase Inhibitors accounted for XX% of Hiv Drugs market in 2022. Non- Nucleoside Reverse Transcriptase Inhibitors (NRTIs) share of XX%.
Hospital Pharmacies accounted for XX% of the Hiv Drugs market in 2022. Retail Pharmacies accounts for XX%.
Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.
COVID-19 Impact:
Outbreak of COVID-19 pandemic due to lockdown restrictions imposed by governments around the world has affected the growth of the global Hiv Drugs market in 2020. The containment measures taken by the governments of various countries in response to control the outbreak of COVID-19 disrupted the entire supply chain by creating logistical interruptions, transportation restrictions, and product supply across borders.
The report analyzes the key trends in each segment of the global Hiv Drugs market along with global and country-level forecasts from 2023 to 2028. Our report segments the market based on types and applications, thereby providing a detailed analysis of the market to help gain an in-depth understanding of the market and enable market participants, stakeholders, investors, etc. to have a clearer understanding of the market and judgment.
Key benefits to stakeholders:
The report provides a comprehensive quantitative analysis of various segments, historical and current market trends, market forecasts, and dynamics of the Hiv Drugs market for 2017-2028.
The research report provides the latest information on the market drivers, challenges and opportunities of the global Hiv Drugs market.
The study profiles the leading as well as the fastest growing regional markets. It further enables stakeholders to identify key country-level markets within each region.
Porter's Five Forces Analysis helps stakeholders assess the impact of new entrants, competitors, supplier strength, buyer strength, and threat of substitution. It helps stakeholders analyze the level of competition in the Hiv Drugs industry and its attractiveness.
The competitive landscape enables stakeholders to understand their competitive environment and gain insight into the current position of the key players in the market.
The life sciences industry grows and continues to advance, driving innovation and improving healthcare outcomes for individuals around the world.
Artificial Intelligence (AI) and Machine Learning (ML): AI and ML technologies are increasingly being employed in life sciences research and development. They aid in drug discovery, optimizing clinical trials, analyzing vast amounts of biological data, and identifying patterns that can lead to breakthroughs in understanding diseases and developing new therapies.
Digital Health Technologies: Digital health technologies have seen rapid growth, especially in areas like telemedicine, wearable devices, and mobile health applications. These technologies enable remote patient monitoring, facilitate better healthcare access, and empower individuals to manage their health more effectively.
Wearable Devices and Remote Monitoring: Wearable devices, such as smartwatches and fitness trackers, have become more sophisticated, enabling continuous monitoring of vital signs and health parameters. These devices offer opportunities for early detection of health issues and improved management of chronic conditions.
Key Regions Covered in This Report Are
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Spain
Nordic
Asia Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Latin America
Brazil
Mexico
Argentina
Middle East & Africa
Egypt
South Africa
UAE
Turkey
Saudi Arabia
Some of the major players operating in the global market include:
ViiV Healthcare (U.S.)
Gilead Sciences Inc. (U.S.)
Glaxo Smith Kline PLC (U.K.)
Merck Sharp & Dohme Corp. (France)
Bristol-Myers Squibb Company (U.S.)
Janssen Pharmaceuticals Inc. (Johnson & Johnson) (Belgium)
Boehringer Ingelheim International GmbH (Germany)
AbbVie Inc. (U.S.)
Genentech Inc. (F. Hoffmann-La Roche AG) (U.S.)
Mylan N.V. (U.S.)
Segment by Type
Integrase Inhibitors
Non- Nucleoside Reverse Transcriptase Inhibitors (NRTIs)
Combination HIV Medicines
Other Drug Classes
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Other Distribution Channels
Table of Content
1 Hiv Drugs Market Introduction and Overview
1.1 Hiv Drugs Definition
1.2 Research Purposes
1.3 Report Timeline
1.4 Economic Analysis of Global Regions
1.5 Inflation Analysis
1.6 The Impact of the Russian-Ukrainian War on the Market
1.7 Coronavirus Disease 2020 (COVID-19) Impact on Global
2 Global Hiv Drugs Historical Market Analysis by Type
2.1 Market Size Analysis by Types
2.2 Global Hiv Drugs Revenue and Market Share by Type
2.3 Global Hiv Drugs Sales and Market Share by Type
3 Global Hiv Drugs Historical Market Analysis by Application
3.1 Market Size Analysis by Application
3.2 Global Hiv Drugs Revenue Market Share by Application (2018-2023)
3.3 Global Hiv Drugs Sales Market Share by Application (2018-2023)
4 Global Market Growth Trends Analysis
4.1 Global Hiv Drugs Market Size (2018-2023)
4.2 Hiv Drugs Growth Trends Analysis by Regions
4.2.1 Hiv Drugs Market Size by Regions: 2018 VS 2023 VS 2029
4.2.2 Hiv Drugs Historic Revenue Market Size by Regions (2018-2023)
4.2.3 Hiv Drugs Historic Sales Market Size by Regions (2018-2023)
4.2.4 North America Hiv Drugs Market Size (2018-2023)
4.2.5 Europe Hiv Drugs Market Size (2018-2023)
4.2.6 Asia-Pacific Hiv Drugs Market Size (2018-2023)
4.2.7 Latin America Hiv Drugs Market Size (2018-2023)
4.2.8 Middle East & Africa Hiv Drugs Market Size (2018-2023)
5 North America
5.1 North America Hiv Drugs Revenue by Countries
5.1.1 North America Hiv Drugs Revenue by Countries (2018-2023)
5.1.2 North America Hiv Drugs Sales by Countries (2018-2023)
5.2 North America Hiv Drugs Sales by Types
5.3 North America Hiv Drugs Sales by Applications
5.4 United States
5.5 Canada
6 Asia Pacific
6.1 Asia Pacific Hiv Drugs Revenue by Countries
6.1.1 Asia Pacific Hiv Drugs Revenue by Countries (2018-2023)
6.1.2 Asia Pacific Hiv Drugs Sales by Countries (2018-2023)
6.2 Asia Pacific Hiv Drugs Sales by Types
6.3 Asia Pacific Hiv Drugs Sales by Applications
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Hiv Drugs Revenue by Countries
7.1.1 Europe Hiv Drugs Revenue by Countries (2018-2023)
7.1.2 Europe Hiv Drugs Sales by Countries (2018-2023)
7.2 Europe Hiv Drugs Sales by Types
7.3 Europe Hiv Drugs Sales by Applications
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Nordic
8 Latin America
8.1 Latin America Hiv Drugs Revenue by Countries
8.1.1 Latin America Hiv Drugs Revenue by Countries (2018-2023)
8.1.2 Latin America Hiv Drugs Sales by Countries (2018-2023)
8.2 Latin America Hiv Drugs Sales by Types
8.3 Latin America Hiv Drugs Sales by Applications
8.4 Brazil
8.5 Argentina
8.6 Mexico
9 Middle East & Africa
9.1 Middle East & Africa Hiv Drugs Revenue by Countries
9.1.1 Middle East & Africa Hiv Drugs Revenue by Countries (2018-2023)
9.1.2 Middle East & Africa Hiv Drugs Sales by Countries (2018-2023)
9.2 Middle East & Africa Hiv Drugs Sales by Types
9.3 Middle East & Africa Hiv Drugs Sales by Applications
9.4 Egypt
9.5 South Africa
9.6 UAE
9.7 Turkey
9.8 Saudi Arabia
10 Global Hiv Drugs Market Competition, by Players
10.1 Global Hiv Drugs Revenue and Market Share by Players
10.2 Market Concentration Rate
10.2.1 Top 3 Hiv Drugs Players Market Share in 2022
10.2.2 Top 6 Hiv Drugs Players Market Share in 2022
10.2.3 Market Competition Trend
10.3 Hiv Drugs Players Head Office, Business Provided
10.4 Hiv Drugs Mergers & Acquisitions
10.5 Hiv Drugs New Entrants and Expansion Plans
11 Players Profiles
11.1 ViiV Healthcare (U.S.)
11.1.1 ViiV Healthcare (U.S.) Company Profile
11.1.2 Hiv Drugs Product Overview
11.1.3 ViiV Healthcare (U.S.) Hiv Drugs Market Performance (2018-2023)
11.1.4 ViiV Healthcare (U.S.) Business Overview
11.1.5 Recent Developments and Plans
11.2 Gilead Sciences Inc. (U.S.)
11.2.1 Gilead Sciences Inc. (U.S.) Company Profile
11.2.2 Hiv Drugs Product Overview
11.2.3 Gilead Sciences Inc. (U.S.) Hiv Drugs Market Performance (2018-2023)
11.2.4 Gilead Sciences Inc. (U.S.) Business Overview
11.2.5 Recent Developments and Plans
11.3 Glaxo Smith Kline PLC (U.K.)
11.3.1 Glaxo Smith Kline PLC (U.K.) Company Profile
11.3.2 Hiv Drugs Product Overview
11.3.3 Glaxo Smith Kline PLC (U.K.) Hiv Drugs Market Performance (2018-2023)
11.3.4 Glaxo Smith Kline PLC (U.K.) Business Overview
11.3.5 Recent Developments and Plans
11.4 Merck Sharp & Dohme Corp. (France)
11.4.1 Merck Sharp & Dohme Corp. (France) Company Profile
11.4.2 Hiv Drugs Product Overview
11.4.3 Merck Sharp & Dohme Corp. (France) Hiv Drugs Market Performance (2018-2023)
11.4.4 Merck Sharp & Dohme Corp. (France) Business Overview
11.4.5 Recent Developments and Plans
11.5 Bristol-Myers Squibb Company (U.S.)
11.5.1 Bristol-Myers Squibb Company (U.S.) Company Profile
11.5.2 Hiv Drugs Product Overview
11.5.3 Bristol-Myers Squibb Company (U.S.) Hiv Drugs Market Performance (2018-2023)
11.5.4 Bristol-Myers Squibb Company (U.S.) Business Overview
11.5.5 Recent Developments and Plans
11.6 Janssen Pharmaceuticals Inc. (Johnson & Johnson) (Belgium)
11.6.1 Janssen Pharmaceuticals Inc. (Johnson & Johnson) (Belgium) Company Profile
11.6.2 Hiv Drugs Product Overview
11.6.3 Janssen Pharmaceuticals Inc. (Johnson & Johnson) (Belgium) Hiv Drugs Market Performance (2018-2023)
11.6.4 Janssen Pharmaceuticals Inc. (Johnson & Johnson) (Belgium) Business Overview
11.6.5 Recent Developments and Plans
11.7 Boehringer Ingelheim International GmbH (Germany)
11.7.1 Boehringer Ingelheim International GmbH (Germany) Company Profile
11.7.2 Hiv Drugs Product Overview
11.7.3 Boehringer Ingelheim International GmbH (Germany) Hiv Drugs Market Performance (2018-2023)
11.7.4 Boehringer Ingelheim International GmbH (Germany) Business Overview
11.7.5 Recent Developments and Plans
11.8 AbbVie Inc. (U.S.)
11.8.1 AbbVie Inc. (U.S.) Company Profile
11.8.2 Hiv Drugs Product Overview
11.8.3 AbbVie Inc. (U.S.) Hiv Drugs Market Performance (2018-2023)
11.8.4 AbbVie Inc. (U.S.) Business Overview
11.8.5 Recent Developments and Plans
11.9 Genentech Inc. (F. Hoffmann-La Roche AG) (U.S.)
11.9.1 Genentech Inc. (F. Hoffmann-La Roche AG) (U.S.) Company Profile
11.9.2 Hiv Drugs Product Overview
11.9.3 Genentech Inc. (F. Hoffmann-La Roche AG) (U.S.) Hiv Drugs Market Performance (2018-2023)
11.9.4 Genentech Inc. (F. Hoffmann-La Roche AG) (U.S.) Business Overview
11.9.5 Recent Developments and Plans
11.10 Mylan N.V. (U.S.)
11.10.1 Mylan N.V. (U.S.) Company Profile
11.10.2 Hiv Drugs Product Overview
11.10.3 Mylan N.V. (U.S.) Hiv Drugs Market Performance (2018-2023)
11.10.4 Mylan N.V. (U.S.) Business Overview
11.10.5 Recent Developments and Plans
12 Global Hiv Drugs Forecast Market Analysis by Type
12.1 Global Hiv Drugs Revenue Market Forecast by Type (2023-2029)
12.2 Global Hiv Drugs Sales Market Forecast by Type (2023-2029)
13 Global Hiv Drugs Forecast Market Analysis by Application
13.1 Hiv Drugs Revenue Market Forecast by Application (2023-2029)
13.2 Hiv Drugs Sales Market Forecast by Application (2023-2029)
14 Global Market Growth Forecast Analysis
14.1 Global Hiv Drugs Forecast Market Size (2023-2029)
14.2 Hiv Drugs Growth Trends Forecast Analysis by Regions
14.2.1 Hiv Drugs Revenue Forecast Market Size by Regions (2023-2029)
14.2.2 Hiv Drugs Sales Forecast Market Size by Regions (2023-2029)
14.2.3 North America Hiv Drugs Forecast Market Size (2023-2029)
14.2.4 Europe Hiv Drugs Forecast Market Size (2023-2029)
14.2.5 Asia-Pacific Hiv Drugs Forecast Market Size (2023-2029)
14.2.6 Latin America Hiv Drugs Forecast Market Size (2023-2029)
14.2.7 Middle East & Africa Hiv Drugs Forecast Market Size (2023-2029)
15 Hiv Drugs Manufacturing Cost Analysis
15.1 Hiv Drugs Key Raw Materials Analysis
15.1.1 Key Raw Materials
15.1.2 Price Trend of Key Raw Materials
15.1.3 Key Suppliers of Raw Materials
15.2 Proportion of Manufacturing Cost Structure
15.2.1 Raw Materials
15.2.2 Labor Cost
15.2.3 Manufacturing Expenses
15.3 Manufacturing Process Analysis of Hiv Drugs
15.4 Hiv Drugs Industrial Chain Analysis
16 Market Channel, Distributors, Traders and Dealers
16.1 Market Channel Status
16.1.1 Direct Marketing
16.1.2 Indirect Marketing
16.2 Hiv Drugs Typical Distributors
16.3 Hiv Drugs Typical Customers
17 Hiv Drugs Industry Dynamic Analysis
17.1 Hiv Drugs Market Trends Analysis
17.2 Hiv Drugs Market Drivers Analysis
17.3 Hiv Drugs Market Challenges Analysis
17.4 Hiv Drugs Market Restraints Analysis
18 Research Findings and Conclusion
Tables & Figures:
List of Tables and Figures
Figure Hiv Drugs Picture
Table Product Definition of Hiv Drugs
Table Economic Analysis of Global Regions
Table Inflation Analysis
Table The Impact of the Russian-Ukrainian War on the Market
Figure 2020 (COVID-19) Impact on Global Economic Growth 2019, 2020, 2021
Figure Population infected by the Covid-19 of Major Countries
Table Global Hiv Drugs Market Size by Type (2018 VS 2023 VS 2029)
Table Global Hiv Drugs Revenue and Market Size by Type (2018-2023)
Table Global Hiv Drugs Revenue and Market Share by Type (2018-2023)
Table Global Hiv Drugs Sales and Market Size by Type (2018-2023)
Table Global Hiv Drugs Sales and Market Share by Type (2018-2023)
Table Global Hiv Drugs Market Size by Application (2018 VS 2023 VS 2029)
Table Global Hiv Drugs Revenue Market Size by Application (2018-2023)
Table Global Hiv Drugs Revenue Market Share by Application (2018-2023)
Table Global Hiv Drugs Sales Market Size by Application (2018-2023)
Table Global Hiv Drugs Sales Market Share by Application (2018-2023)
Figure Global Hiv Drugs Revenue Market Size (2018-2023)
Figure Global Hiv Drugs Sales Market Size (2018-2023)
Table Hiv Drugs Market Size by Regions: 2018 VS 2023 VS 2029
Table Hiv Drugs Historic Revenue Market Size by Regions (2018-2023)
Table Hiv Drugs Historic Revenue Market Share by Regions (2018-2023)
Table Hiv Drugs Historic Sales Market Size by Regions (2018-2023)
Table Hiv Drugs Historic Sales Market Share by Regions (2018-2023)
Figure North America Hiv Drugs Market Size (2018-2023)
Figure Europe Hiv Drugs Market Size (2018-2023)
Figure Asia-Pacific Hiv Drugs Market Size (2018-2023)
Figure Latin America Hiv Drugs Market Size (2018-2023)
Figure Middle East & Africa Hiv Drugs Market Size (2018-2023)
Table North America Hiv Drugs Revenue by Countries (2018-2023)
Table North America Hiv Drugs Revenue Market Share by Countries (2018-2023)
Table North America Hiv Drugs Sales by Countries (2018-2023)
Table North America Hiv Drugs Sales Market Share by Countries (2018-2023)
Table North America Hiv Drugs Sales by Types (2018-2023)
Table North America Hiv Drugs Sales Market Share by Types (2018-2023)
Table North America Hiv Drugs Sales by Applications (2018-2023)
Table North America Hiv Drugs Sales Market Share by Applications (2018-2023)
Figure United States Hiv Drugs Revenue and Growth (2018-2023)
Figure United States Hiv Drugs Sales and Growth (2018-2023)
Figure Canada Hiv Drugs Revenue and Growth (2018-2023)
Figure Canada Hiv Drugs Sales and Growth (2018-2023)
Table Asia-Pacific Hiv Drugs Revenue by Countries (2018-2023)
Table Asia-Pacific Hiv Drugs Revenue Market Share by Countries (2018-2023)
Table Asia-Pacific Hiv Drugs Sales by Countries (2018-2023)
Table Asia-Pacific Hiv Drugs Revenue Market Share by Countries (2018-2023)
Table Asia Pacific Hiv Drugs Sales by Types (2018-2023)
Table Asia Pacific Hiv Drugs Sales Market Share by Types (2018-2023)
Table Asia Pacific Hiv Drugs Sales by Applications (2018-2023)
Table Asia Pacific Hiv Drugs Sales Market Share by Applications (2018-2023)
Figure China Hiv Drugs Revenue and Growth (2018-2023)
Figure China Hiv Drugs Sales and Growth (2018-2023)
Figure Japan Hiv Drugs Revenue and Growth (2018-2023)
Figure Japan Hiv Drugs Sales and Growth (2018-2023)
Figure Korea Hiv Drugs Revenue and Growth (2018-2023)
Figure Korea Hiv Drugs Sales and Growth (2018-2023)
Figure Southeast Asia Hiv Drugs Revenue and Growth (2018-2023)
Figure Southeast Asia Hiv Drugs Sales and Growth (2018-2023)
Figure India Hiv Drugs Revenue and Growth (2018-2023)
Figure India Hiv Drugs Sales and Growth (2018-2023)
Figure Australia Hiv Drugs Revenue and Growth (2018-2023)
Figure Australia Hiv Drugs Sales and Growth (2018-2023)
Table Europe Hiv Drugs Revenue by Countries (2018-2023)
Table Europe Hiv Drugs Revenue Market Share by Countries (2018-2023)
Table Europe Hiv Drugs Sales by Countries (2018-2023)
Table Europe Hiv Drugs Sales Market Share by Countries (2018-2023)
Table Europe Hiv Drugs Sales by Types (2018-2023)
Table Europe Hiv Drugs Sales Market Share by Types (2018-2023)
Table Europe Hiv Drugs Sales by Applications (2018-2023)
Table Europe Hiv Drugs Sales Market Share by Applications (2018-2023)
Figure Germany Hiv Drugs Revenue and Growth (2018-2023)
Figure Germany Hiv Drugs Sales and Growth (2018-2023)
Figure France Hiv Drugs Revenue and Growth (2018-2023)
Figure France Hiv Drugs Sales and Growth (2018-2023)
Figure UK Hiv Drugs Revenue and Growth (2018-2023)
Figure UK Hiv Drugs Sales and Growth (2018-2023)
Figure Italy Hiv Drugs Revenue and Growth (2018-2023)
Figure Italy Hiv Drugs Sales and Growth (2018-2023)
Figure Russia Hiv Drugs Revenue and Growth (2018-2023)
Figure Russia Hiv Drugs Sales and Growth (2018-2023)
Figure Spain Hiv Drugs Revenue and Growth (2018-2023)
Figure Spain Hiv Drugs Sales and Growth (2018-2023)
Figure Nordic Hiv Drugs Revenue and Growth (2018-2023)
Figure Nordic Hiv Drugs Sales and Growth (2018-2023)
Table Latin America Hiv Drugs Revenue by Countries (2018-2023)
Table Latin America Hiv Drugs Revenue Market Share by Countries (2018-2023)
Table Latin America Hiv Drugs Sales by Countries (2018-2023)
Table Latin America Hiv Drugs Sales Market Share by Countries (2018-2023)
Table Latin America Hiv Drugs Sales by Types (2018-2023)
Table Latin America Hiv Drugs Sales Market Share by Types (2018-2023)
Table Latin America Hiv Drugs Sales by Applications (2018-2023)
Table Latin America Hiv Drugs Sales Market Share by Applications (2018-2023)
Figure Brazil Hiv Drugs Revenue and Growth (2018-2023)
Figure Brazil Hiv Drugs Sales and Growth (2018-2023)
Figure Argentina Hiv Drugs Revenue and Growth (2018-2023)
Figure Argentina Hiv Drugs Sales and Growth (2018-2023)
Figure Mexico Hiv Drugs Revenue and Growth (2018-2023)
Figure Mexico Hiv Drugs Sales and Growth (2018-2023)
Table Middle East & Africa Hiv Drugs Revenue by Countries (2018-2023)
Table Middle East & Africa Hiv Drugs Revenue Market Share by Countries (2018-2023)
Table Middle East & Africa Hiv Drugs Sales by Countries (2018-2023)
Table Middle East & Africa Hiv Drugs Sales Market Share by Countries (2018-2023)
Table Middle East & Africa Hiv Drugs Sales by Types (2018-2023)
Table Middle East & Africa Hiv Drugs Sales Market Share by Types (2018-2023)
Table Middle East & Africa Hiv Drugs Sales by Applications (2018-2023)
Table Middle East & Africa Hiv Drugs Sales Market Share by Applications (2018-2023)
Figure Egypt Hiv Drugs Revenue and Growth (2018-2023)
Figure Egypt Hiv Drugs Sales and Growth (2018-2023)
Figure South Africa Hiv Drugs Revenue and Growth (2018-2023)
Figure South Africa Hiv Drugs Sales and Growth (2018-2023)
Figure UAE Hiv Drugs Revenue and Growth (2018-2023)
Figure UAE Hiv Drugs Sales and Growth (2018-2023)
Figure Turkey Hiv Drugs Revenue and Growth (2018-2023)
Figure Turkey Hiv Drugs Sales and Growth (2018-2023)
Figure Saudi Arabia Hiv Drugs Revenue and Growth (2018-2023)
Figure Saudi Arabia Hiv Drugs Sales and Growth (2018-2023)
Table Global Hiv Drugs Revenue by Players (2018-2023)
Table Global Hiv Drugs Revenue Market Share by Players (2018-2023)
Figure Global Top 3 Companies Revenue Share in 2022
Figure Global Top 6 Companies Revenue Share in 2022
Table Global Hiv Drugs Players Market Concentration Ratio (CR5) (2018-2023)
Table Hiv Drugs Players Head Office, Business Provided
Table Mergers & Acquisitions
Table New Entrants and Expansion Plans
Table ViiV Healthcare (U.S.) Profile
Table Product Overview
Table ViiV Healthcare (U.S.) Hiv Drugs Sales, Price, Revenue, Gross and Gross Margin (2018-2023)
Figure ViiV Healthcare (U.S.) Sales and Growth Rate
Figure ViiV Healthcare (U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table Gilead Sciences Inc. (U.S.) Profile
Table Product Overview
Table Gilead Sciences Inc. (U.S.) Hiv Drugs Sales, Price, Revenue, Gross and Gross Margin (2018-2023)
Figure Gilead Sciences Inc. (U.S.) Sales and Growth Rate
Figure Gilead Sciences Inc. (U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table Glaxo Smith Kline PLC (U.K.) Profile
Table Product Overview
Table Glaxo Smith Kline PLC (U.K.) Hiv Drugs Sales, Price, Revenue, Gross and Gross Margin (2018-2023)
Figure Glaxo Smith Kline PLC (U.K.) Sales and Growth Rate
Figure Glaxo Smith Kline PLC (U.K.) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table Merck Sharp & Dohme Corp. (France) Profile
Table Product Overview
Table Merck Sharp & Dohme Corp. (France) Hiv Drugs Sales, Price, Revenue, Gross and Gross Margin (2018-2023)
Figure Merck Sharp & Dohme Corp. (France) Sales and Growth Rate
Figure Merck Sharp & Dohme Corp. (France) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table Bristol-Myers Squibb Company (U.S.) Profile
Table Product Overview
Table Bristol-Myers Squibb Company (U.S.) Hiv Drugs Sales, Price, Revenue, Gross and Gross Margin (2018-2023)
Figure Bristol-Myers Squibb Company (U.S.) Sales and Growth Rate
Figure Bristol-Myers Squibb Company (U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table Janssen Pharmaceuticals Inc. (Johnson & Johnson) (Belgium) Profile
Table Product Overview
Table Janssen Pharmaceuticals Inc. (Johnson & Johnson) (Belgium) Hiv Drugs Sales, Price, Revenue, Gross and Gross Margin (2018-2023)
Figure Janssen Pharmaceuticals Inc. (Johnson & Johnson) (Belgium) Sales and Growth Rate
Figure Janssen Pharmaceuticals Inc. (Johnson & Johnson) (Belgium) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table Boehringer Ingelheim International GmbH (Germany) Profile
Table Product Overview
Table Boehringer Ingelheim International GmbH (Germany) Hiv Drugs Sales, Price, Revenue, Gross and Gross Margin (2018-2023)
Figure Boehringer Ingelheim International GmbH (Germany) Sales and Growth Rate
Figure Boehringer Ingelheim International GmbH (Germany) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table AbbVie Inc. (U.S.) Profile
Table Product Overview
Table AbbVie Inc. (U.S.) Hiv Drugs Sales, Price, Revenue, Gross and Gross Margin (2018-2023)
Figure AbbVie Inc. (U.S.) Sales and Growth Rate
Figure AbbVie Inc. (U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table Genentech Inc. (F. Hoffmann-La Roche AG) (U.S.) Profile
Table Product Overview
Table Genentech Inc. (F. Hoffmann-La Roche AG) (U.S.) Hiv Drugs Sales, Price, Revenue, Gross and Gross Margin (2018-2023)
Figure Genentech Inc. (F. Hoffmann-La Roche AG) (U.S.) Sales and Growth Rate
Figure Genentech Inc. (F. Hoffmann-La Roche AG) (U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table Mylan N.V. (U.S.) Profile
Table Product Overview
Table Mylan N.V. (U.S.) Hiv Drugs Sales, Price, Revenue, Gross and Gross Margin (2018-2023)
Figure Mylan N.V. (U.S.) Sales and Growth Rate
Figure Mylan N.V. (U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table Global Hiv Drugs Revenue Market Size Forecast by Type (2023-2029)
Table Global Hiv Drugs Revenue Market Share Forecast by Type (2023-2029)
Table Global Hiv Drugs Sales Market Size Forecast by Type (2023-2029)
Table Global Hiv Drugs Sales Market Share Forecast by Type (2023-2029)
Table Global Hiv Drugs Revenue Market Size by Application (2023-2029)
Table Global Hiv Drugs Revenue Market Share by Application (2023-2029)
Table Global Hiv Drugs Sales Market Size by Application (2023-2029)
Table Global Hiv Drugs Sales Market Share by Application (2023-2029)
Figure Global Hiv Drugs Revenue Forecast Market Size (2023-2029)
Figure Global Hiv Drugs Sales Forecast Market Size (2023-2029)
Table Hiv Drugs Revenue Forecast Market Size by Regions (2023-2029)
Table Hiv Drugs Revenue Forecast Market Share by Regions (2023-2029)
Table Hiv Drugs Sales Forecast Market Size by Regions (2023-2029)
Table Hiv Drugs Sales Forecast Market Share by Regions (2023-2029)
Figure North America Hiv Drugs Revenue Forecast Market Size (2023-2029)
Figure North America Hiv Drugs Sales Forecast Market Size (2023-2029)
Figure Europe Hiv Drugs Revenue Forecast Market Size (2023-2029)
Figure Europe Hiv Drugs Sales Forecast Market Size (2023-2029)
Figure Asia-Pacific Hiv Drugs Revenue Forecast Market Size (2023-2029)
Figure Asia-Pacific Hiv Drugs Sales Forecast Market Size (2023-2029)
Figure Latin America Hiv Drugs Revenue Forecast Market Size (2023-2029)
Figure Latin America Hiv Drugs Sales Forecast Market Size (2023-2029)
Figure Middle East & Africa Hiv Drugs Forecast Market Size (2023-2029)
Figure Middle East & Africa Hiv Drugs Sales Forecast Market Size (2023-2029)
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Table Raw Materials Analysis
Table Labor Cost Analysis
Table Manufacturing Expenses Analysis
Figure Manufacturing Process Analysis of Hiv Drugs
Figure Hiv Drugs Industrial Chain Analysis
Table Distributors of Hiv Drugs with Contact Information
Table Major Customers of Hiv Drugs with Contact Information
Table Market Trends Analysis
Table Market Drivers Analysis
Table Market Challenges Analysis
Table Market Restraints Analysis
Research Methodology:
Global Hiv Drugs Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|